Multiple Sclerosis

Latest News

Prolonged COVID-19 Symptoms Prevalent in Patients With Multiple Sclerosis

Publish Date January 19, 2022

In a prospective and longitudinal cohort study, researchers examined the course of recovery from COVID-19 among patients with MS and sought to identify its predictors, such as patients’ physical and mental health status before COVID-19 infection.

COVID-19 Hospitalization Not Tied to Rituximab Timing, Dose in Patients With MS

Publish Date January 14, 2022

Researchers sought to examine the association between timing and dose of rituximab and hospitalization for COVID-19 in patients with multiple sclerosis in Sweden.

Immunosuppressive Therapies and COVID-19 Risk in Children With Neuroimmunologic Disorders

Publish Date January 13, 2022

In a retrospective survey, researchers assessed whether children receiving immunosuppressive therapies for neuroimmunologic diseases were disproportionately affected by COVID-19.

Visual Complaints Common Among Patients With Multiple Sclerosis

Publish Date January 12, 2022

General practitioners may not discuss vision-related quality of life for people with MS, and may infrequently refer them to appropriate care.

COVID-19 mRNA Vaccines Effective in Patients With MS on Disease-Modifying Drugs

Publish Date January 11, 2022

Researchers sought to determine the efficacy of COVID-19 mRNA vaccines and immune-specific response of patients with MS treated with various disease-modifying drugs.

Loss of Balance Trends in Patients With Multiple Sclerosis and Parkinson Disease

Publish Date January 10, 2022

Researchers sought to systematically classify loss of balance trends among patients with multiple sclerosis and Parkinson disease.

Multiple Sclerosis and Pregnancy: Outcomes of Early Dimethyl Fumarate Exposure

Publish Date January 7, 2022

Using data from a prospective, international registry, researchers assessed whether delayed-release dimethyl fumarate exposure affects pregnancy and infant outcomes among pregnant women with multiple sclerosis.

Rituximab-Induced Hypogammaglobulinemia and Infection Risk in Multiple Sclerosis

Publish Date January 6, 2022

In a prospective observational study, researchers investigated the incidence of hypogammaglobulinemia and infections in patients with MS who were treated with rituximab in the MS center of Marseille, France.

Ublituximab Under Review for Relapsing Forms of Multiple Sclerosis

Publish Date January 4, 2022

Ublituximab is an investigational glycoengineered monoclonal antibody that targets CD20.

The Effect of Erythropoietin on Visual Outcomes in Optic Neuritis

Publish Date December 30, 2021

In a phase 3 trial, researchers assessed the safety and efficacy of erythropoietin in patients with optic neuritis as a clinically isolated syndrome.